Company page
Cosmo Pharmaceuticals Nv
Cosmo Pharmaceuticals NV, trading under the ticker COPN, is a public company based in Switzerland. With a market capitalization of approximately 1.39 billion Swiss francs, Cosmo focuses on developing innovative products in the pharmaceutical sector. The company is dedicated to advancing healthcare solutions and improving patient outcomes through its research and development efforts.
- Ticker
- COPN:SIX
- Asset type
- Stock
- Market cap
- $1.39B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SIX
- Currency
- CHF